Saol Therapeutics Inc

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain	Osteoarthritis Knee Pain	Recruiting	Phase 3	2026-08-25		NCT07226258
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pyruvate Dehydrogenase Complex Deficiency Disease, Pyruvate Metabolism, Inborn Errors, X-linked disease, brain disorder, central nervous system disorder, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, intellectual disability, metabolic disease, nervous system disorder	Active, not recruiting	Phase 3	2025-05-04		NCT02616484

Clinical trials